CIK 0001341235
- Non-accelerated filer
- Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- Open-market buys, last 90 days
- $140,275
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$140,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-11 | Machatha Stephen Chief Development Officer | Sale | −22,073 | $5.15 | $114K | 221,799 |
| 2025-03-04 | Machatha Stephen Chief Development Officer | Grant or award · Stock Option (right to buy) | +202,427 | 202,427 | ||
| 2024-08-12 | Machatha Stephen Chief Development Officer | Sale | −16,041 | $4.74 | $76K | 236,771 |
| 2024-03-12 | Machatha Stephen Chief Development Officer | Sale | −11,537 | $3.16 | $37K | 252,812 |
| 2024-03-12 | Machatha Stephen Chief Development Officer | Sale | −11,537 | $3.16 | $37K | 243,495 |
| 2024-03-11 | Machatha Stephen Chief Development Officer | Sale | −18,231 | $3.41 | $62K | 255,032 |
| 2024-03-09 | Machatha Stephen Chief Development Officer | Grant or award · Stock Option (right to buy) | +405,450 | 405,450 | ||
| 2023-02-28 | Machatha Stephen Chief Development Officer | Grant or award · Stock Option (right to buy) | +220,258 | 220,258 | ||
| 2022-07-15 | Machatha Stephen Chief Development Officer | Grant or award | +185,605 | 273,263 | ||
| 2022-07-15 | Machatha Stephen Chief Development Officer | Grant or award · Bonus Units | +69,473 | 69,473 | ||
| 2022-03-30 | Machatha Stephen Chief Development Officer | Grant or award | +64,395 | 87,658 | ||
| 2022-03-30 | Machatha Stephen Chief Development Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2021-04-12 | Machatha Stephen Chief Development Officer | Grant or award · Employee Stock Option (Right to Buy) | +116,201 | 116,201 |
Page 1 of 1 · 13 trades